Thulium Laser and KeraFactor for the Treatment of Androgenetic Alopecia

Exclusion Criteria

• •Subjects does not have the capacity to consent to the study
• •Subject has other types of alopecia of the scalp (i.g., alopecia areata, scarring alopecia)
• •Use of minoxidil or 5-alpha reductase inhibitors (i.e., finasteride, dutasteride) 3 months prior to screening date.
• •Any medical condition that in the consideration of the investigator, would present an increased risk of a photosensitivity reaction to the subject.
• •Pregnant in the last 12 months, intending to become pregnant, postpartum or nursing in the last 12 months.
• •Any previous surgical procedure in the treatment area in the past 12 months, or major surgery in the last 6 months.
• •History of immunosuppression/immune deficiency disorders (including AIDS and HIV infection), and/or any history of systemic chemotherapy for prior 12 months.
• •History or current use of the following prescription medications: Immunosuppressive medications/biologics, 6 months prior to and during the study. Accutane or other systemic retinoids within the past twelve months.
• •Smoking or vaping in the past 12 months.
• •History of hyperlipidemia, diabetes mellitus, hepatitis, or bleeding disorders.
• •History of major depressive disorders or endocrine disorders including but not limited to; hypothyroidism, Hashimoto's thyroiditis, or hyperthyroidism as well as Polycystic Ovarian Syndrome (PCOS) in females.